FDA warns against use of OTC benzocaine teething products

The FDA has taken action to stop the use of over-the-counter benzocaine oral health products for young children, stating that the products “pose serious safety risks, especially those with no demonstrated benefit.” In addition to warning consumers that these products, which are intended for the temporary relief of sore gums due to teething, pose a serious risk to infants and children, the administration has asked companies to stop selling the products for such use.

More…